J. W. Miller

发表

Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.

Joan W. Miller, T. Hasan, E. Gragoudas, 1996, Ophthalmology.

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.

Joan W. Miller, E. Gragoudas, T. Flotte, 1996, Archives of ophthalmology.

Transscleral delivery of bioactive protein to the choroid and retina.

K Miyamoto, E S Gragoudas, Joan W. Miller, 2000, Investigative ophthalmology & visual science.

Phthalocyanine photodynamic therapy of experimental iris neovascularization.

C. Puliafito, W. Stinson, J. W. Miller, 1991, Ophthalmology.

Necrotic enlargement of cone photoreceptor cells and the release of high-mobility group box-1 in retinitis pigmentosa

Y. Murakami, D. Vavvas, T. Hisatomi, 2015, Cell Death Discovery.

Proton beam therapy for age-related macular degeneration: development of a standard plan.

E. Gragoudas, J. Munzenrider, J. W. Miller, 1999, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium

Y. Murakami, D. Vavvas, B. Ksander, 2015, Cell Death and Disease.

Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment

J. Avruch, H. Lin, Y. Murakami, 2014, Cell Death and Disease.

Retinal artery occlusion in rabbit eyes using human atheroma.

T. Ciulla, J. W. Miller, R. Moulton, 1995, Current eye research.

Interferon-associated retinopathy.

J. S. Kelley, Joan W. Miller, J. Slakter, 1993, Archives of ophthalmology.

Necrotic cone photoreceptor cell death in retinitis pigmentosa

Y. Murakami, S. Nakatake, J. W. Miller, 2015, Cell Death and Disease.

Photosensitizer delivery for photodynamic therapy of choroidal neovascularization.

J. W. Miller, R. Renno, Joan W. Miller, 2001, Advanced drug delivery reviews.

Diffusion of high molecular weight compounds through sclera.

Ivana K. Kim, E S Gragoudas, Joan W. Miller, 2000, Investigative ophthalmology & visual science.

Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration

Joan W. Miller, M. Kayama, A. Thanos, 2013, Cell Death and Differentiation.

Vascular endothelial growth factor and ocular neovascularization.

J. W. Miller, 1997, The American journal of pathology.

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.

N. Bressler, Joan W. Miller, C. Pournaras, 2000, Archives of ophthalmology.

Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.

E. Gragoudas, T. Flotte, D. Husain, 1997, Ophthalmology.

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

R Birngruber, E S Gragoudas, N. Bressler, 1999, Archives of ophthalmology.

Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells.

Joan W. Miller, F. Delori, E. Gragoudas, 2000, Investigative ophthalmology & visual science.

Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

J. Folkman, A. Adamis, J. W. Miller, 1995 .

Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina.

Joan W. Miller, C. Pournaras, E. Gragoudas, 1997, Archives of ophthalmology.

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

E S Gragoudas, Joan W. Miller, E. Gragoudas, 1996, Archives of ophthalmology.

Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.

Ivana K. Kim, Joan W. Miller, A. Adamis, 1999, Investigative ophthalmology & visual science.

Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

Joan W. Miller, J. Folkman, H. Dvorak, 1994, The American journal of pathology.

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

Joan W. Miller, E. Gragoudas, A. Adamis, 1996, Ophthalmology.

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.

Joan W. Miller, E. Gragoudas, A. Adamis, 1996, Archives of ophthalmology.

The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.

P. Campochiaro, J. W. Miller, S. Ryan, 1999, Molecular vision.

Best's macular dystrophy.

J. W. Miller, A. Youssri, 2001, International ophthalmology clinics.

Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.

Joan W. Miller, D. Shima, A. Adamis, 1996, Investigative ophthalmology & visual science.

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

R Birngruber, E S Gragoudas, N. Bressler, 1999, Archives of ophthalmology.

Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death

Joan W. Miller, Y. Murakami, D. Vavvas, 2015, Cell Death and Disease.

Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.

T J Flotte, E S Gragoudas, Joan W. Miller, 1999, Ophthalmology.

Regression of experimental iris neovascularization with systemic alpha-interferon.

W. Stinson, J. Folkman, J. W. Miller, 1993, Ophthalmology.

Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Joan W. Miller, E. Gragoudas, T. Flotte, 1999, Investigative ophthalmology & visual science.

Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.

T J Flotte, E S Gragoudas, Joan W. Miller, 1995, Archives of ophthalmology.

Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.

E. Gragoudas, D. Husain, A. Adamis, 2000, Archives of ophthalmology.

Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

L. Aiello, Joan W. Miller, A. Adamis, 1997, Diabetes/metabolism reviews.

Endothelin-1-mediated retinal artery vasospasm and the rabbit electroretinogram.

M. Sandberg, B. Pawlyk, A. Harris, 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

VLA‐4 blockade suppresses endotoxin‐induced uveitis: in vivo evidence for functional integrin up‐regulation

T. Nakazawa, E. Gragoudas, A. Hafezi-Moghadam, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration

J M Seddon, J. D. de Boer, J. Seddon, 2008, British Journal of Ophthalmology.

Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.

T. Hasan, E. Gragoudas, T. Flotte, 1997, Current eye research.